hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression

References

• Gill J, Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol. 2021;18(10):609–11. doi:10.1038/s41571-021-00519-8.
   PubMed Web of Science ®Google Scholar
• Belayneh R, Fourman MS, Bhogal S, Weiss KR. Update on osteosarcoma. Curr Oncol Rep. 2021;23(6):71. doi:10.1007/s11912-021-01053-7.
   PubMed Web of Science ®Google Scholar
• Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39–50. doi:10.1080/14737140.2018.1413939.
   PubMed Web of Science ®Google Scholar
• Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell. 2022;185(12):2016–2034. doi:10.1016/j.cell.2022.04.021.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular rnas. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Xu D, Chen X, Li S, Zhang L, Chan MTV, Wu WKK. An update on the roles of circular RNAs in osteosarcoma. Cell Prolif. 2021;54(1):e12936. doi:10.1111/cpr.12936.
   PubMed Web of Science ®Google Scholar
• Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J. Circece1 activates energy metabolism in osteosarcoma by stabilizing c-myc. Mol Cancer. 2020;19(1):151. doi:10.1186/s12943-020-01269-4.
   PubMed Web of Science ®Google Scholar
• Ma XL, Zhan TC, Hu JP, Zhang CL, Zhu KP. Doxorubicin-induced novel circrna_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating mcl1 through mir-142-5p. Cell Death Discov. 2021;7(1):309. doi:10.1038/s41420-021-00694-8.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu G, Wu Y, Ma J, Wu H, Xie Z, Chen S, Yang Y, Wang S, Shen P, et al. Circmyo10 promotes osteosarcoma progression by regulating mir-370-3p/ruvbl1 axis to enhance the transcriptional activity of β-catenin/lef1 complex via effects on chromatin remodeling. Mol Cancer. 2019;18(1):150. doi:10.1186/s12943-019-1076-1.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M. Deciphering miRNAs’ action through miRNA editing. Int J Molecular Sci. 2019;20(24):6249. doi:10.3390/ijms20246249.
   PubMed Web of Science ®Google Scholar
• Cai WT, Guan P, Lin MX, Fu B, Wu B, Wu J. miRNA-206 suppresses the metastasis of osteosarcoma via targeting notch3. J Biol Regul Homeost Agents. 2020;34(3):775–783. doi:10.23812/20-72-A-26.
   PubMed Web of Science ®Google Scholar
• Zhu KP, Zhang CL, Ma XL, Hu JP, Cai T, Zhang L. Analyzing the interactions of mRNAs and ncrnas to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol Therapy: J Amer Soc Gene Therap. 2019;27(3):518–530. doi:10.1016/j.ymthe.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Wang S, Su TT, Tong H, Shi W, Ma F, Quan Z. Circpvt1 promotes gallbladder cancer growth by sponging mir-339-3p and regulates mcl-1 expression. Cell Death Discov. 2021;7(1):191. doi:10.1038/s41420-021-00577-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Su TT, Tong H, Shi W, Ma F, Quan Z. Correction: Circpvt1 promotes gallbladder cancer growth by sponging mir-339-3p and regulates mcl-1 expression. Cell Death Discov. 2021;7(1):396. doi:10.1038/s41420-021-00669-9.
   PubMed Web of Science ®Google Scholar
• Zhou C, Lu Y, Li X. Mir-339-3p inhibits proliferation and metastasis of colorectal cancer. Oncol Lett. 2015;10(5):2842–2848. doi:10.3892/ol.2015.3661.
   PubMed Web of Science ®Google Scholar
• He M, Wang Z, Zhao J, Chen Y, Wu Y. Col1a1 polymorphism is associated with risks of osteosarcoma susceptibility and death. Tumor Biol. 2014;35(2):1297–1305. doi:10.1007/s13277-013-1172-6.
   PubMedGoogle Scholar
• Zhang C, Liu S, Wang X, Liu H, Zhou X, Liu H, Ilie L. Col1a1 is a potential prognostic biomarker and correlated with immune infiltration in mesothelioma. Biomed Res Int. 2021;2021:1–13. doi:10.1155/2021/5320941.
   PubMed Web of Science ®Google Scholar
• Jia R, Wang C. MiR-29b-3p reverses cisplatin resistance by targeting COL1A1 in non-small-cell lung cancer A549/DDP cells. Cancer Manag Res. 2020;12:2559–2566. doi:10.2147/CMAR.S246625.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T, Shu Y. Circrnas in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90. doi:10.1186/s13045-019-0776-8.
   PubMed Web of Science ®Google Scholar
• Xi Y, Fowdur M, Liu Y, Wu H, He M, Zhao J. Differential expression and bioinformatics analysis of circrna in osteosarcoma. Biosci Rep. 2019;39(5). doi:10.1042/BSR20181514.
   Google Scholar
• Jin J, Chen A, Qiu W, Chen Y, Li Q, Zhou X, Jin D. Dysregulated circrna_100876 suppresses proliferation of osteosarcoma cancer cells by targeting microRNA-136. J Cellular Biochem. 2019;120(9):15678–15687. doi:10.1002/jcb.28837.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang L, Cao L, Wei T. Novel circular RNA circatrnl1 accelerates the osteosarcoma aerobic glycolysis through targeting mir-409-3p/ldha. Bioengineered. 2021;12(2):9965–9975. doi:10.1080/21655979.2021.1985343.
   PubMed Web of Science ®Google Scholar
• Trakunram K, Chaniad P, Geater SL, Keeratichananont W, Chittithavorn V, Uttayamakul S, Buya S, Raungrut P, Thongsuksai P. Serum mir-339-3p as a potential diagnostic marker for non-small cell lung cancer. Cancer Biol Med. 2020;17(3):652–663. doi:10.20892/j.issn.2095-3941.2020.0063.
   PubMed Web of Science ®Google Scholar
• Weber CE, Luo C, Hotz-Wagenblatt A, Gardyan A, Kordaß T, Holland-Letz T, Osen W, Eichmüller SB. Mir-339-3p is a tumor suppressor in melanoma. Cancer Res. 2016;76(12):3562–3571. doi:10.1158/0008-5472.CAN-15-2932.
   PubMed Web of Science ®Google Scholar
• Geng Q, Shen Z, Li L, Zhao J. Col1a1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer. PeerJ. 2021;9:e11145. doi:10.7717/peerj.11145.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun R, Zhao X, Sun B. Runx2 promotes malignant progression in gastric cancer by regulating col1a1. Cancer biomarkers: section a of disease markers. Cancer Biomark. 2021;31(3):227–238. doi:10.3233/CBM-200472.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Y, Zhang J, Zhong J, Yang R. Col1a1 promotes metastasis in colorectal cancer by regulating the wnt/pcp pathway. Mol Med Report. 2018;17(4):5037–5042. doi:10.3892/mmr.2018.8533.
   PubMed Web of Science ®Google Scholar
• Huang P, Li M, Tang Q, Jiang K, Luo Y. Circ_0000523 regulates mir-1184/col1a1/pi3k/akt pathway to promote nasopharyngeal carcinoma progression. Apoptosis 2022;27(9–10):751–761. doi:10.1007/s10495-022-01743-y.
   PubMed Web of Science ®Google Scholar